AET01
Table 1 (Default) Overview of Deaths and Adverse Events Summary Table 1.
Source: R/aet01.R
aet01.Rd
AET01
Table 1 (Default) Overview of Deaths and Adverse Events Summary Table 1.
Usage
aet01_main(
adam_db,
arm_var = "ACTARM",
lbl_overall = NULL,
anl_vars = list(safety_var = c("FATAL", "SER", "SERWD", "SERDSM", "RELSER", "WD",
"DSM", "REL", "RELWD", "RELDSM", "SEV")),
anl_lbls = "Total number of {patient_label} with at least one",
...
)
aet01_pre(adam_db, ...)
aet01_post(tlg, prune_0 = FALSE, ...)
aet01
Arguments
- adam_db
(
list
ofdata.frames
) object containing theADaM
datasets- arm_var
(
string
) variable used for column splitting- lbl_overall
(
string
) label used for overall column, if set toNULL
the overall column is omitted- anl_vars
Named (
list
) of (character
) variables the safety variables to be summarized.- anl_lbls
(
character
) of analysis labels.- ...
not used.
- tlg
(
TableTree
,Listing
orggplot
) object typically produced by amain
function.- prune_0
(
flag
) remove 0 count rows
Value
the main function returns an rtables
object.
the preprocessing function returns a list
of data.frame
.
the postprocessing function returns an rtables
object or an ElementaryTable
(null report).
Note
adam_db
object must contain anadsl
table with the"DTHFL"
and"DCSREAS"
columns.adam_db
object must contain anadae
table with the columns passed toanl_vars
.
Examples
run(aet01, syn_data, arm_var = "ARM")
#> A: Drug X B: Placebo C: Combination
#> (N=15) (N=15) (N=15)
#> —————————————————————————————————————————————————————————————————————————————————————————————————————
#> Total number of patients with at least one AE 13 (86.7%) 14 (93.3%) 15 (100%)
#> Total number of AEs 58 59 99
#> Total number of deaths 2 (13.3%) 4 (26.7%) 3 (20.0%)
#> Total number of patients withdrawn from study due to an AE 0 0 1 (6.7%)
#> Total number of patients with at least one
#> AE with fatal outcome 8 (53.3%) 8 (53.3%) 10 (66.7%)
#> Serious AE 12 (80.0%) 12 (80.0%) 11 (73.3%)
#> Serious AE leading to withdrawal from treatment 0 0 2 (13.3%)
#> Serious AE leading to dose modification/interruption 4 (26.7%) 3 (20.0%) 4 (26.7%)
#> Related Serious AE 8 (53.3%) 8 (53.3%) 10 (66.7%)
#> AE leading to withdrawal from treatment 2 (13.3%) 3 (20.0%) 3 (20.0%)
#> AE leading to dose modification/interruption 6 (40.0%) 9 (60.0%) 11 (73.3%)
#> Related AE 11 (73.3%) 10 (66.7%) 13 (86.7%)
#> Related AE leading to withdrawal from treatment 0 3 (20.0%) 0
#> Related AE leading to dose modification/interruption 1 (6.7%) 4 (26.7%) 9 (60.0%)
#> Severe AE (at greatest intensity) 11 (73.3%) 10 (66.7%) 12 (80.0%)